USPTO serial 77387921
DIATOS
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- FARRELL, ANNE M
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with DIATOS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Dean R. Karau
DEAN R. KARAU FREDRIKSON & BYRON, P.A.200 S 6TH ST STE 4000MINNEAPOLIS, MN 55402-1425UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical, biochemical, biological, biotechnological products and preparations, other than for medical or veterinary purposes, namely, nucleic acids, proteins, antibiotics, antiviral molecules and immunomodulators, toxines and antineoplastics for the pharmaceutical industry and for science; chemical, biochemical, biological and biotechnological products, namely, nucleic acids, proteins, antibiotics, antiviral molecules and immunomodulators, toxines and antineoplastics for laboratory analyses, other than for medical or veterinary purposes; diagnostic preparations, other than for medical or veterinary purposes; chemical reagents, other than for medical or veterinary purposes | ACTIVE | — |
| 005 | Pharmaceuticals and medicines for the treatment of oncological, dermatological, infectious, endocrinological, immunological, and hematological diseases; Pharmaceutical solutions used in oncology, dermatology, endocrinology, immunology, infections and hematology; Pharmaceutical preparations for the treatment of cancer and diabetes; Biological preparations for medical purposes; Biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use; Chemical clinical and medical diagnostic reagents for medical or veterinary purposes; Diagnostic agents, preparations and substances for medical purposes; Diagnostic preparations for clinical or medical laboratory use; Nucleic acid sequences and chemical reagents for medical and veterinary purposes; chemical or biochemical products, namely, nucleic acids, proteins, antibiotics, antiviral molecules, immunomodulators, toxines and antineoplastics for the treatment of viral, bacterial, fungal and parasitic infections, cancer, degenerative diseases, autoimmune diseases and dermatological diseases | ACTIVE | — |
| 042 | Basic and clinical research in the field of respiratory science and medicine; Consulting services in the field of science; providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto; Providing information in the field of science; laboratory research in the field of biology, biotechnology, pharmacy and medicine; Technology consultation and research in the field of biology, biotechnology, pharmacy and medicine | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by DIATOS SA
- Other trademarks owned by DIATOS SA
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named DIATOS
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 19, 2010 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jan 18, 2010 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jun 16, 2009 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 24, 2009 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 4, 2009 | NPUB | NOTICE OF PUBLICATION | — |
| Feb 18, 2009 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Feb 18, 2009 | ALIE | ASSIGNED TO LIE | — |
| Feb 9, 2009 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 9, 2009 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 9, 2009 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 9, 2009 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 9, 2009 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Dec 14, 2008 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 14, 2008 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 14, 2008 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 10, 2008 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 10, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 10, 2008 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 13, 2008 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 13, 2008 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 13, 2008 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 13, 2008 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 7, 2008 | NWAP | NEW APPLICATION ENTERED | — |